Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.9K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.7K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

843
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
843
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

46.0K
VSEPR Theory for Determination of Electron Pair Geometries
46.0K
Prediction Intervals01:03

Prediction Intervals

3.4K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Astragalus membranaceus Ameliorates Endometrial Aging and Restores Receptivity by Enhancing Mitochondrial Function in Stromal and Epithelial Cells.

Protein & cell·2026
Same author

Single-Cell and Spatial Analysis Reveal the Differences Between Left-Sided and Right-Sided Colorectal Cancer.

Cell proliferation·2026
Same author

A quantitative approach for defining the degradability landscape of protein degraders.

Nature communications·2026
Same author

Bimodality in pan-cancer proteomics reveals new opportunities for biomarker discovery.

Genome biology·2026
Same author

Applying Artificial Intelligence and machine learning in precision nutrition.

Nature communications·2026
Same author

AI systems devise hypotheses and ways to test them.

Nature·2026

Related Experiment Video

Updated: Feb 7, 2026

Deep Learning-Based Segmentation of Cryo-Electron Tomograms
10:25

Deep Learning-Based Segmentation of Cryo-Electron Tomograms

Published on: November 11, 2022

10.8K

PAIRWISE: Deep Learning-based Prediction of Effective Personalized Drug Combinations in Cancer.

Olivier Elemento1,2,3, Chengqi Xu1, Ilkay Us4

  • 1Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.

Research Square
|February 6, 2026
PubMed
Summary

This study introduces PAIRWISE, a novel computational model for predicting synergistic drug combinations in cancer. PAIRWISE accurately identifies effective personalized cancer therapies, advancing precision oncology.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.6K
DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
04:17

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

Published on: May 10, 2024

1.6K

Related Experiment Videos

Last Updated: Feb 7, 2026

Deep Learning-Based Segmentation of Cryo-Electron Tomograms
10:25

Deep Learning-Based Segmentation of Cryo-Electron Tomograms

Published on: November 11, 2022

10.8K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.6K
DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
04:17

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning

Published on: May 10, 2024

1.6K

Area of Science:

  • Computational biology
  • Oncology
  • Pharmacology

Background:

  • Combination therapies are crucial for enhancing cancer treatment efficacy and preventing recurrence.
  • Identifying optimal drug combinations is challenging due to numerous possibilities and tumor heterogeneity.
  • Preclinical screening can prioritize synergistic drug combinations, but personalized approaches are needed.

Purpose of the Study:

  • To develop a computational model, PAIRWISE, for predicting synergistic drug combinations in cancer.
  • To address the challenge of identifying personalized drug combinations tailored to specific cancer subtypes and patients.
  • To accelerate the development of precision oncology through effective nomination of drug combinations.

Main Methods:

  • Developed PAIRWISE, a model explicitly designed to predict synergistic effects of drug combinations.
  • Applied PAIRWISE to held-out cancer cell lines and an independent dataset of Diffuse Large B Cell Lymphoma (DLBCL) treated with Bruton Tyrosine Kinase (BTK) inhibitors.
  • Validated predictions using high-throughput screening (HTS) of approved or investigational agents for DLBCL.

Main Results:

  • PAIRWISE demonstrated superior performance compared to competing models, achieving an AUROC of 0.847 on cancer cell lines.
  • The model accurately predicted synergistic combinations in DLBCL with an AUROC of 0.720.
  • PAIRWISE showed strong concordance with in vitro screening results, validating its predictive capability.

Conclusions:

  • PAIRWISE effectively models synergistic drug effects and nominates personalized drug combinations for cancer treatment.
  • The model shows significant potential for accelerating precision oncology development.
  • This approach can guide the selection of effective combination therapies for individual patients.